Article Versions Notes

Stalin J, Imhof BA, Coquoz O, Jeitziner R, Hammel P, McKee TA, Jemelin S, Poittevin M, Pocard M, Matthes T, et al. Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy. Cancers. 2021; 13(18):4625. https://doi.org/10.3390/cancers13184625

Stalin, Jimmy, Beat A. Imhof, Oriana Coquoz, Rachel Jeitziner, Philippe Hammel, Thomas A. McKee, Stephane Jemelin, Marine Poittevin, Marc Pocard, Thomas Matthes, and et al. 2021. "Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy" Cancers 13, no. 18: 4625. https://doi.org/10.3390/cancers13184625

Stalin, J., Imhof, B. A., Coquoz, O., Jeitziner, R., Hammel, P., McKee, T. A., Jemelin, S., Poittevin, M., Pocard, M., Matthes, T., Kaci, R., Delorenzi, M., Rüegg, C., & Miljkovic-Licina, M. (2021). Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy. Cancers, 13(18), 4625. https://doi.org/10.3390/cancers13184625